Related Experiment Videos
Tryptamine receptors in rat pulmonary artery
British Journal of Pharmacology
|July 1, 1974
Summary
Tryptamine and 5-hydroxytryptamine (5-HT) equally contract rat pulmonary arteries. These vascular 5-HT receptors are blocked by methysergide and morphine, indicating they differ from other known 5-HT receptor types.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Neuroscience
Background:
- 5-hydroxytryptamine (5-HT), also known as serotonin, plays a crucial role in various physiological processes.
- Understanding the specific receptors mediating 5-HT's vascular effects is essential for developing targeted therapies.
Purpose of the Study:
- To characterize the 5-HT receptors in the rat pulmonary artery and lung vasculature.
- To investigate the effects of methysergide and morphine on these 5-HT receptors.
Main Methods:
- Isolated rat pulmonary artery spiral strips were used to assess contractile responses to tryptamine and 5-HT.
- A perfused rat isolated lung model was employed to measure changes in perfusion pressure induced by 5-HT.
- The effects of methysergide and morphine as antagonists were evaluated in both models.
Main Results:
- Tryptamine and 5-HT demonstrated equipotent contractile effects on rat pulmonary artery strips.
- Low concentrations of methysergide and morphine effectively blocked these 5-HT-induced contractions.
- In the perfused lung, 5-HT increased perfusion pressure, an effect also antagonized by methysergide and morphine.
Conclusions:
- The vascular 5-HT receptors in the rat pulmonary artery and lung are sensitive to methysergide and morphine.
- These receptors are distinct from previously classified M or D receptors.
- The identified receptors differ from those involved in mediating spasmogen release in rat lungs.